APA (7th ed.) Citation

P, V., I, D. G., C, T., R, S., E, A., A, N., . . . R, A. (2026). Current status and perspective of immunotherapy for head and neck squamous cell carcinoma. Expert opinion on investigational drugs, 35(2), 151. https://doi.org/10.1080/13543784.2026.2627205

Chicago Style (17th ed.) Citation

P, Vitale, Di Giovanni I, Tammaro C, Spedaliere R, Amler E, Necas A, Scrima M, Caraglia M, and Addeo R. "Current Status and Perspective of Immunotherapy for Head and Neck Squamous Cell Carcinoma." Expert Opinion on Investigational Drugs 35, no. 2 (2026): 151. https://doi.org/10.1080/13543784.2026.2627205.

MLA (9th ed.) Citation

P, Vitale, et al. "Current Status and Perspective of Immunotherapy for Head and Neck Squamous Cell Carcinoma." Expert Opinion on Investigational Drugs, vol. 35, no. 2, 2026, p. 151, https://doi.org/10.1080/13543784.2026.2627205.